SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is experiencing significant volatility and heightened trading activity as the market aggressively reprices storage stocks amid intense AI-driven infrastructure demand. The community is actively debating whether this movement represents a structural, long-term supercycle in memory and storage or an overextended speculative bubble driven by retail FOMO and institutional rotation.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing heightened volatility and intense social media debate, driven by institutional adoption concerns and speculation regarding the sustainability of corporate holding strategies. The community is sharply divided, with bearish voices highlighting macroeconomic pressures and technical chart patterns, while bullish proponents view the current price action as an accumulation opportunity and a necessary correction before potential future gains.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs remains a focal point for investors as they monitor high steel pricing against ongoing debt concerns and the high-stakes potential of a strategic partnership with POSCO. Community sentiment is deeply divided, with many traders debating whether the stock is an undervalued infrastructure play linked to AI-driven demand or a high-risk asset hampered by corporate leadership.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. The firm focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan is currently trending as investors weigh recent leadership succession updates and bank dividend hikes against a broader rotation in the financials sector. The community is actively discussing the bank's long-term capital strategy, its potential for major acquisitions, and its role as a defensive anchor amidst ongoing market volatility.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors engage in intense speculation and debate regarding potential Russell 1000 index inclusion, fueling high options activity and volatility. The community remains divided, with bulls emphasizing long-term growth catalysts like ANKTIVA and global expansion, while others warn of market manipulation and potential pullbacks following the rebalancing.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is experiencing intense volatility as investors debate whether the recent surge to all-time highs marks a sustainable breakout or a bull trap. Market participants are closely watching technical indicators and the potential for a sharp pullback, even as community sentiment remains divided between long-term confidence in AI data infrastructure demand and concerns over a possible technical correction.

Aave is a decentralized money market protocol where users can lend and borrow cryptocurrency across 20 different assets as collateral. The protocol has a native token called AAVE, which is also a governance token that lets the community decide the direction of the protocol in a collective manner. Lenders can&nbsp;earn interest by providing liquidity to the market, while borrowers can borrow by collateralizing their cryptoassets to take out loans from the liquidity pools.

AAVE

AAVE is trending following its recent integration with MetaMask Mobile and the launch of a new savings app designed to compete with traditional banking, fueling community optimism around its long-term growth. Investors are actively discussing the protocol's protocol revenue, potential for institutional RWA adoption, and its comparative valuation against DeFi rivals.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors speculate on a major buyout and a potential short squeeze, fueled by record short interest and intense community focus on the stock's upward momentum. Discussion is heavily concentrated on the extreme pressure building on short sellers to cover their positions as the community anticipates imminent clinical trial catalysts.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is trending as the community debates a potential rebound fueled by the return of NBCUniversal channels and excitement surrounding the FIFA World Cup. While bulls point to these catalysts and institutional price targets as signs of a turnaround, bears remain focused on historical share price declines, insider selling, and ongoing skepticism regarding the company's long-term profitability.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is seeing heightened activity as market participants closely watch the regulatory outcome for RGX-121 following recent safety concerns and a clinical hold. The community is actively debating the potential for a complete response letter versus a delayed decision, while many are also analyzing the company's cash position and the strategic implications of its partnership with AbbVie for the broader retinal program.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wave Life Sciences (WVE) Upgraded to Buy: Here's Why

Wave Life Sciences (WVE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Strength Seen in Intellia Therapeutics (NTLA): Can Its 23.2% Jump Turn into More Strength?

Intellia Therapeutics (NTLA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter

This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter...

Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1

Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 PR Newswire DURHAM, N.C., May 19, 2026 The...

WVE Stock Edges Up After Positive Early Data For Rare Disease Drug  

Equity

The Cambridge-based biotech said its drug WVE-006 produced promising effects in patients with the most severe form of alpha-1 antitrypsin deficiency.

HC Wainwright Expects Higher Earnings for WAVE Life Sciences

WAVE Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities research analysts at HC Wainwright upped their Q2 2026 earnings estimates for WAVE Life Sciences in a report issued on Wednesday, April 29th. HC Wainwright analyst A. Fein now expects that the company will post earnings per share of ($0.3...

Pictet Asset Management Holding SA Purchases 790,175 Shares of WAVE Life Sciences Ltd. $WVE

Pictet Asset Management Holding SA boosted its holdings in shares of WAVE Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 5,024.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 805...

WAVE Life Sciences (NASDAQ:WVE) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen raised shares of WAVE Life Sciences from a "strong sell" rating to a "hold" rating in a research report on Saturday...

WAVE Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of "Moderate Buy" by Analysts

WAVE Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) has been given a consensus rating of "Moderate Buy" by the fifteen research firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and fourteen have i...

WAVE Life Sciences (NASDAQ:WVE) Given New $43.00 Price Target at Canaccord Genuity Group

Canaccord Genuity Group dropped their price target on shares of WAVE Life Sciences from $52.00 to $43.00 and set a "buy" rating on the stock in a research note on Thursday...

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It develops and commercializes a pipeline of RNA medicines across a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

WVEWave Life Sciences Ltd

Latest WVE News